Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 732,769 | 747,049 | 715,931 | 726,796 | 789,839 |
| Cost of Goods | 334,333 | 309,614 | 314,333 | 326,169 | 329,619 |
| Gross Profit | 398,436 | 437,435 | 401,598 | 400,627 | 460,220 |
| Operating Expenses | 280,881 | 281,245 | 277,149 | 299,934 | 275,228 |
| Operating Income | 117,888 | 156,804 | 124,782 | 100,862 | 185,611 |
| Interest Expense | 364 | 426 | 363 | 398 | 4,703 |
| Other Income | -2,144,673 | 4,865,848 | 1,032,356 | 1,196,739 | 907,994 |
| Pre-tax Income | -2,027,149 | 5,022,226 | 1,156,775 | 1,297,203 | 1,088,902 |
| Income Tax | -461,845 | 1,094,193 | 242,661 | 319,789 | 241,838 |
| Net Income Continuous | -1,565,304 | 3,928,033 | 914,114 | 977,414 | 847,064 |
| Net Income | $-1,565,304 | $3,928,033 | $914,114 | $977,414 | $847,064 |
| EPS Basic Total Ops | -52.62 | 131.75 | 30.71 | 32.77 | 28.33 |
| EPS Basic Continuous Ops | -52.63 | 131.75 | 30.71 | 32.77 | 28.33 |
| EPS Diluted Total Ops | -51.83 | 129.96 | 30.32 | 32.38 | 27.96 |
| EPS Diluted Continuous Ops | -51.83 | 129.96 | 30.32 | 32.38 | 27.96 |
| EBITDA(a) | $117,888 | $156,804 | $124,782 | $100,862 | $185,611 |